Given the efficacy of Serp-1 treatment in reducing vascular inflammation and in atherosclerosis, Serp-1 treatment was assessed in rat and mouse aortic and rat renal allograft transplant models for transplant rejection and transplant vasculitis. This evidence concerns the gene SERP1 and atherosclerosis.